Skip to main content
. 2018 Mar 26;58(6):814–822. doi: 10.1002/jcph.1077

Table 5.

Mean (%CV) SBECD Pharmacokinetic Parameters Following IV Administration of Delafloxacin 300 mg (Containing 2400 mg SBECD) to ESRD Patients

Plasma Pharmacokinetics Dosing Before Hemodialysis Dosing After Hemodialysis
Cmax (μg·hr/mL) 238 (24.6) 304 (28.3)
AUC0‐48 2715 (58.3) 7861 (31.6)

AUC indicates area under the concentration‐time curve; Cmax, peak concentration; %CV, coefficient of variation; ESRD, end‐stage renal disease; IV, intravenous; SBECD, sulfobutylether‐β‐cyclodextrin.